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The insulin-like growth factors (IGF-I and IGF-11) are a family of proteins with both 
growth-promoting and insulin-like activity. Several lines of evidence indicate IGFs 
may serve as autocrine growth factors in the developing nervous system. IGF 
transcripts are abundant in human fetal brain,' and in vitro, IGFs stimulate DNA 
synthesis and proliferation of cultured fetal neuroblasts.2 The actions of the IGFs are 
influenced by a family of high affinity binding proteins, designated 1GFBPs.l IGFBPs 
can modulate both the binding of IGFs to the type I and I1 IGF receptors and the 
distribution of IGFs among tissue compartments.' In  the current study, we examined 
gene and protein expression of IGFBPs in a well-characterized model system of 
neuronal growth, cultured human SH-SYSY neuroblastoma c e k 3  These cells, which 
express IGF-I1 and the type I and I1 IGF receptors, provide a good in vitro model for 
studying potential neuronal IGF-IGFBP interactions. 
SH-SYSY cells were cultured, as previously described, in the absence and 
presence of serum.3 Total RNA was analyzed by RNase protection.' cDNA clones 
were obtained from Dr. S. Shimasaki (IGFBP-2,4, 5,6) and Dr. D. Powell (IGFBP- 
1, 3). Protected fragments were quantitated using a radioanalytic scanner (Ambis, 
San Diego, Calif.). Conditioned medium from SH-SYSY cells, grown under serum- 
free conditions, was analyzed by western ligand b l~ t t i ng .~  
RNase protection assays revealed four protected fragments corresponding to 
IGFBP-2 through IGFBP-5 (FIGURE 1). There was no detectable IGFBP-1 or 6. The 
major transcript present was IGFBP-2 with approximately fourfold less expression of 
IGFBP-4 and barely detectable amounts of IGFBP-3 and 5. This pattern of gene 
expression parallels previously reported patterns in cerebrospinal fluid, brain, and 
cultured neural lines.5 Using western ligand blotting, SH-SYSY cells secreted four 
IGFBPs with MI estimates of 24,000, 30,000, 34,000, and 46,000 (FIGURE 2). The 
major secreted forms were the 34,000 and the 24,000 forms, which likely corre- 
sponded to IGFBP-2 and IGFBP-4, respectively. A similar IGFBP secretion profile 
has been reported in other neural cell lines.5 
In summary, human SH-SYSY cells secreted four IGFBPs with M ,  estimates of 
24,000, 30,000, 34,000, and 46,000. The major secreted forms, with MI estimates of 
34,000 and 24,000, likely represented IGFBP-2 and IGFBP-4, respectively. Gene 
expression, determined by RNase protection assays, reflected protein secretion. The 
two major transcripts present were IGFBP-2 and IGFBP-4, with lesser amounts of 
IGFBP-3 and 5. Neither IGFBP-1 nor IGFBP-6 was detected by ligand blotting or 
RNase protection. As an initial step towards understanding the role of IGFBPs in 
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FIGURE 1.  Radioanalytic scanner counts of IGFBP RNase protection assay of cultured 
SH-SYSY neuroblastoma cells. The cRNA probes used to detect IGFBP mRNA were 
transcribed from different portions of the cDNAs. Protected fragments were quantitated by 
radioanalytic scanning. 









FIGURE 2. Ligand blot analysis of SH-SYSY conditioned medium (CM). CM from either 
control ovarian carcinoma cells (lane A) or SH-SYSY neuroblastoma cells was concentrated 
20-fold and electrophoresed through a 10% sodium dodecyl sulfate-polyacrylamide gel under 
nonreducing conditions. Proteins were electroblotted onto a nitrocellulose membrane and 
exposed to '2s1-IGF-II. Tentative identification of IGFBPs was made based on M ,  estimates. 
264 ANNALS NEW YORK ACADEMY OF SCIENCES 
neuronal ontogeny, we have begun examining changes in IGFBP gene and protein 
expression during neuronal differentiation.6 
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